OpenLegislation

Annex II ESSENTIAL MEDICAL USES

United Kingdom

Original text. Later amendments are not shown.

Quota of controlled substances of Group I that may be used in the production of metered-dose inhalers (MDIs) for the treatment of asthma and other chronic obstructive pulmonary diseases (COPDs) are allocated to:

  • 3M (UK)

  • Aventis (UK)

  • Bespak (UK)

  • Boehringer Ingelheim (DE)

  • Chiesi (IT)

  • Glaxo Smith Kline (UK)

  • IG Sprühtechnik (DE)

  • Inyx Pharmaceuticals (UK)

  • IVAX (IE)

  • Jaba Farmaceutica (PT)

  • Lab. Aldo-Union (ES)

  • Otsuka Pharmaceuticals (ES)

  • Sicor (IT)

  • Schering-Plough (BE)

  • V.A.R.I. (IT)

  • Valeas (IT)

  • Valois (FR)